Annual Short Term Debt
$1.30 M
+$215.00 K+19.78%
April 30, 2024
Summary
- As of February 8, 2025, KALV annual short term debt is $1.30 million, with the most recent change of +$215.00 thousand (+19.78%) on April 30, 2024.
- During the last 3 years, KALV annual short term debt has risen by +$439.00 thousand (+50.87%).
- KALV annual short term debt is now -70.64% below its all-time high of $4.43 million, reached on December 31, 2014.
Performance
KALV Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$1.54 M
+$273.00 K+21.60%
October 31, 2024
Summary
- As of February 8, 2025, KALV quarterly short term debt is $1.54 million, with the most recent change of +$273.00 thousand (+21.60%) on October 31, 2024.
- Over the past year, KALV quarterly short term debt has increased by +$235.00 thousand (+18.05%).
- KALV quarterly short term debt is now -76.71% below its all-time high of $6.60 million, reached on March 31, 2015.
Performance
KALV Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
KALV Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.8% | +18.1% |
| 3 y3 years | +50.9% | +65.3% |
| 5 y5 years | +100.0% | +155.3% |
KALV Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.9% | at high | +57.3% |
| 5 y | 5-year | at high | -100.0% | at high | +264.2% |
| alltime | all time | -70.6% | -100.0% | -76.7% | -100.0% |
KalVista Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | $1.54 M(+21.6%) |
| Jul 2024 | - | $1.26 M(-2.9%) |
| Apr 2024 | $1.30 M(+19.8%) | $1.30 M(+9.7%) |
| Jan 2024 | - | $1.19 M(+3.4%) |
| Oct 2023 | - | $1.15 M(+2.3%) |
| Jul 2023 | - | $1.12 M(+3.2%) |
| Apr 2023 | $1.09 M(+11.3%) | $1.09 M(+2.8%) |
| Jan 2023 | - | $1.06 M(+3.0%) |
| Oct 2022 | - | $1.03 M(+2.9%) |
| Jul 2022 | - | $997.00 K(+2.0%) |
| Apr 2022 | - | $977.00 K(-3.6%) |
| Apr 2022 | $977.00 K(+13.2%) | - |
| Jan 2022 | - | $1.01 M(+9.0%) |
| Oct 2021 | - | $930.00 K(+2.8%) |
| Jul 2021 | - | $905.00 K(+4.9%) |
| Apr 2021 | $863.00 K(+46.8%) | $863.00 K(+45.8%) |
| Jan 2021 | - | $592.00 K(+40.3%) |
| Oct 2020 | - | $422.00 K(-17.7%) |
| Jul 2020 | - | $513.00 K(-12.8%) |
| Apr 2020 | $588.00 K | $588.00 K(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jan 2020 | - | $592.00 K(-1.7%) |
| Oct 2019 | - | $602.00 K(+3.8%) |
| Jul 2019 | - | $580.00 K(>+9900.0%) |
| Apr 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jan 2019 | - | $109.00 K(-30.6%) |
| Oct 2018 | - | $157.00 K(-26.6%) |
| Jul 2018 | - | $214.00 K(-3.2%) |
| Apr 2018 | $221.00 K(-84.8%) | $221.00 K(-0.5%) |
| Jan 2018 | - | $222.00 K(+0.9%) |
| Oct 2017 | - | $220.00 K(+8.9%) |
| Jul 2017 | - | $202.00 K(-89.6%) |
| Mar 2016 | - | $1.95 M(+34.0%) |
| Dec 2015 | $1.46 M(-67.2%) | $1.46 M(+50.8%) |
| Sep 2015 | - | $965.00 K(+101.0%) |
| Jun 2015 | - | $480.00 K(-92.7%) |
| Mar 2015 | - | $6.60 M(+48.8%) |
| Dec 2014 | $4.43 M(+44.8%) | $4.43 M(+1.0%) |
| Sep 2014 | - | $4.39 M(+43.3%) |
| Dec 2013 | $3.06 M(+14.1%) | $3.06 M |
| Dec 2012 | $2.69 M | - |
FAQ
- What is KalVista Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals annual short term debt year-on-year change?
- What is KalVista Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for KalVista Pharmaceuticals?
- What is KalVista Pharmaceuticals quarterly short term debt year-on-year change?
What is KalVista Pharmaceuticals annual short term debt?
The current annual short term debt of KALV is $1.30 M
What is the all time high annual short term debt for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high annual short term debt is $4.43 M
What is KalVista Pharmaceuticals annual short term debt year-on-year change?
Over the past year, KALV annual short term debt has changed by +$215.00 K (+19.78%)
What is KalVista Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of KALV is $1.54 M
What is the all time high quarterly short term debt for KalVista Pharmaceuticals?
KalVista Pharmaceuticals all-time high quarterly short term debt is $6.60 M
What is KalVista Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, KALV quarterly short term debt has changed by +$235.00 K (+18.05%)